期刊
ELIFE
卷 9, 期 -, 页码 -出版社
ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.55331
关键词
-
类别
资金
- National Institutes of Health [2R01GM108799-05, 5R01GM108580-06, 5K08GM126336-03]
- Taylor Family Institute for Innovative Psychiatric Research
This study examines how site-specific binding to three identified neurosteroid-binding sites in the alpha(1)beta(3) GABA(A) receptor (GABA(A)R) contributes to neurosteroid allosteric modulation. We found that the potentiating neurosteroid, allopregnanolone, but not its inhibitory 3 beta-epimer epi-allopregnanolone, binds to the canonical beta(3)(+)-alpha(1)(-) intersubunit site that mediates receptor activation by neurosteroids. In contrast, both allopregnanolone and epi-allopregnanolone bind to intrasubunit sites in the beta(3) subunit, promoting receptor desensitization and the alpha(1) subunit promoting effects that vary between neurosteroids. Two neurosteroid analogues with diazirine moieties replacing the 3-hydroxyl (KK148 and KK150) bind to all three sites, but do not potentiate GABA(A)R currents. KK148 is a desensitizing agent, whereas KK150 is devoid of allosteric activity. These compounds provide potential chemical scaffolds for neurosteroid antagonists. Collectively, these data show that differential occupancy and efficacy at three discrete neurosteroid-binding sites determine whether a neurosteroid has potentiating, inhibitory, or competitive antagonist activity on GABA(A)Rs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据